Educational information, not medical advice — ask your doctor or midwife.
Di Yu (Sanguisorba officinalis root) is one of the most important hemostatic herbs in Traditional Chinese Medicine, used for over 2,000 years. It has a cool, bitter nature and is said to 'cool the blood and stop bleeding' — particularly for bleeding in the lower body. Beyond TCM, related species have been used in European and Indigenous American herbal traditions for similar wound-healing purposes.
Di Yu's rich tannin content — especially ellagitannins like sanguiin H-6 — tightens tissues and blood vessels, reducing bleeding and inflammation at wound sites. Its saponins and polyphenols have demonstrated antibacterial effects and help protect damaged skin from infection. Internally, these compounds help calm an irritated gut lining, reduce inflammatory signaling, and support normal blood clotting.
In China, Di Yu is most commonly prepared as a decoction (boiled root tea) for internal use, or as a topical paste or ointment for burns and skin wounds. Capsules and granules are increasingly available for convenience. Topical preparations are often preferred for burn treatment in clinical settings.
Di Yu has been documented in the Shennong Bencao Jing (Divine Farmer's Classic of Materia Medica), one of the oldest Chinese herbal texts, placing its recorded use back roughly 2,000 years. It has been a go-to remedy in Chinese military and field medicine for treating battlefield wounds and burns, and remains a standard herb in modern TCM dermatology and gastroenterology.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Di Yu is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.